Suven Life Sciences announces first patient randomized in Phase-2b clinical trial of Ropanicant
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
The audit has been concluded with no major observations
ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
The CR Bio unit represents a non-core legacy asset with limited strategic alignment to our core CDMO operations
Subscribe To Our Newsletter & Stay Updated